Skandinaviska Enskilda Banken Ab (Publ) Sanofi Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$45.46 - $50.51 $2.02 Million - $2.25 Million	-44,500 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$45.3 - $51.62 $584,370 - $665,898	-12,900 Reduced 22.47%	44,500 $2.16 Million
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $113,781 - $123,671	-2,300 Reduced 3.85%	57,400 $2.88 Million
Q2 2020 Aug 13, 2020	SELL	$42.91 - $52.5 $1.12 Million - $1.37 Million	-26,000 Reduced 30.34%	59,700 $3.05 Million
Q1 2020 May 13, 2020	BUY	$38.02 - $51.66 $3.26 Million - $4.43 Million	85,700 New	85,700 $3.75 Million

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.